BRIEF-Ariad announces submission of marketing authorization application for Brigatinib
February 06, 2017 at 08:01 AM EST
* Ariad announces submission of marketing authorization application for Brigatinib to the European Medicines Agency
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.